Combined effects of quercetin and α-tocopherol on lipids and glycoprotein components in isoproterenol induced myocardial infarcted Wistar rats

Chemico-Biological Interactions

Volumn 181, Issue 3, 2009, Pages 322-327

  Punithavathi, V R ^a   Prince, P Stanely Mainzen ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Tocopherol; Glycoprotein components; Isoproterenol; Lipids; Myocardial infarction; Quercetin

Indexed keywords

ALPHA TOCOPHEROL; CHOLESTEROL; FATTY ACID; FUCOSE; GLYCOPROTEIN; HEXOSAMINE; HEXOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; ISOPRENALINE; LIPID; LIPID HYDROPEROXIDE; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PHOSPHOLIPID; QUERCETIN; SIALIC ACID; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FATTY ACID BLOOD LEVEL; HEART INFARCTION; LIPID PEROXIDATION; MALE; MONOTHERAPY; NONHUMAN; PHOSPHOLIPID BLOOD LEVEL; RAT; TRIACYLGLYCEROL BLOOD LEVEL; WISTAR RAT;

ALPHA-TOCOPHEROL; ANIMALS; GLYCOPROTEINS; ISOPROTERENOL; LIPID METABOLISM; MALE; MYOCARDIAL INFARCTION; QUERCETIN; RATS; RATS, WISTAR;

RATTUS; RATTUS NORVEGICUS;

EID: 70249106324     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2009.07.002     Document Type: Article

References (50)

1. Nirmala C., and Puvanakrishnan R. Protective role of curcumin against isoproterenol induced myocardial infarction in rats. Mol. Cell. Biochem. 159 (1996) 85-93
2. Ravichandran L.V., Puvanakrishanan R., and Joseph K.T. Alterations in the heart lysosomal stability in isoproterenol induced myocardial infarction in rats. Biochem. Int. 22 (1990) 387-396
3. Dhawan S., Kapoor N.K., and Nityanand S. Effect of isoprenaline on lipid profile and cardiac enzymes in rats. Ind. J. Exp. Biol. 16 (1978) 376-378
4. Nirmala C., and Puvanakrishnan R. Effect of curcumin on certain lysosomal hydrolases in isoproterenol-induced myocardial infarction in rats. Biochem. Pharmacol. 51 (1996) 47-51
5. Chagoya de Sanchez V., Hernandez-Munoz R., Lopez-Barrera F., Yanez L., Vidrio S., Suarez J., Cota-Garza M.D., Aranda-Fraustro A., and Cruz D. Sequential changes of energy metabolism and mitochondrial function in myocardial infarction induced by isoproterenol in rats: a long-term and integrative study. Can. J. Physiol. Pharmacol. 75 (1997) 1300-1311
6. Sushama Kumari S., Varghese A., Muraleedharan D., and Menon V.P. Protective action of aspirin in experimental myocardial infarction induced by isoproterenol in rats and its effect on lipid peroxidation. Ind. J. Exp. Biol. 28 (1990) 480-485
7. Chen Y., Li X., Zhao B., Zheng R., and Xin W. Superoxide and hydroxyl radical sca, venging activities of rutin and other natural products studied by ESR. Biophys. Acta 5 (1989) 253-260
8. Sesso H.D., Gaziano J.M., Liu S., and Buring J.E. Flavonoid intake and the risk of cardiovascular disease in women. Am. J. Clin. Nutr. 77 (2003) 1400-1408
9. In: Cody V., Middleton Jr. E., Harbone J.B., and Beretz A. (Eds). Plant Flavonoids in Biology and Medicine. II. Biochemical, Cellular and Medicinal Properties (1988), AR. Liss. Inc., NewYork 1-461
10. Hertog M.G., Bueno-de-Mesquita H.B., Fehily A.M., Sweetnam P.M., Elwood P.C., and Kromhout D. Fruit and vegetable consumption and cancer mortality in the Caerphilly study. Cancer Epidemiol. Biomarkers Prev. 5 (1996) 673-677
11. Sestili P., Guidarelli A., Dacha M., and Cantoni O. Quercetin prevents DNA single strand breakage and cytotoxicity caused by tert-butylhydroperoxide: free radical scavenging versus iron chelating mechanism. Free Radic. Biol. Med. 25 (1998) 196-200
12. Taguchi K., Hagiwara Y., Kajiyama K., and Suzuki Y. Phamacological studies of Houttuyniae herba: the anti-inflammatory effect of quercitrin. Yakuga Zasshi 113 (1993) 327-333
13. Soleas G.J., Grass L., Josphy P.D., Goldberg D.M., and Diamandis E.P. A comparison of the anti-carcinogenic properties of four red wine polyphenols. Clin. Biochem. 35 (2002) 119-124
14. Martin M.J., Motilva V., and Lastra A.D.L. Quercetin and naringenin; effects on ulcer formation and gastric secretion in rats. Phytother. Res. 7 (1993) 150-153
15. Wargovich M.J., Eng V.W.S., and Newmark H.L. Inhibition by plant phenols of benzo[a] pyrene-induced nuclear aberrations in mammalian intestinal cells: a rapid in vivo assessment method. Food Chem. Toxicol. 23 (1985) 47-49
16. Russo M., Palumbo R., Tedesco I., Mazzarella G., Russo P., Iacomino G., and Russo G.L. Quercetin and anti-CD95 (Fas/APO1) enhance apoptosis in HPB-cell line. FEBS Lett. 462 (1999) 322-328
17. Durate J., Vizcaino F.P., Utrilla P., Jimenez J., Tamarago J., and Zarzuelo A. Vasodilatory effects of flavonoids in rat aortic smooth muscles; structure-activity relationships. J. Pharmacol. 24 (1993) 857-862
18. De Whalley C.V., Rankin S.M., Hoult J.R., Jessup W., and Leake D.S. Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages. Biochem. Pharmacol. 39 (1990) 1743-1750
19. Tappel A.L. VitaminE and free radical peroxidation of lipid. Ann. N. Y. Acad. Sci. 203 (1972) 12-28
20. Gey K.F., Puska P., Jordan P., and Moser U.K. Inverse correlation between plasma vitamin E and mortality from ischaemic heart disease in cross-cultural epidemiology. Am. J. Clin. Nutr. 53 Suppl. (1991) S326-S334
21. Rajadurai M., and Stanely Mainzen Prince P. Preventive effect of naringin on lipids, lipoproteins and lipid metabolic enzymes in isoproterenol-induced myocardial infarction in Wistar rats. J. Biochem. Mol. Toxicol. 20 (2006) 191-197
22. Rajadurai M., and Stanely Mainzen Prince P. Preventive effect of naringin on isoproterenol-induced cardiotoxicity in Wistar rats: an in vivo and in vitro study. Toxicology 232 (2007) 216-225
23. Yagi K. Lipid peroxides and human diseases. Chem. Phys. Lipids 45 (1987) 337-351
24. Jiang Z.Y., Hunt J.V., and Wolff S.P. Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein. Anal. Biochem. 202 (1992) 384-389
25. Folch J., Lees M., and Sloane S.G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226 (1957) 497-509
26. Zlatkis A., Zak B., and Boyle A.J. A new method for the direct determination of serum cholesterol. J. Lab. Clin. Med. 41 (1953) 486-492
27. Fossati P., and Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin. Chem. 28 (1982) 2077-2080
28. Falholt K., Lund B., and Falholt W. An easy colorimetric method for routine determination of free fatty acids in plasma. Clin. Chim. Acta 46 (1973) 105-111
29. Zilversmit D.B., and Davis A.K. Microdetermination of plasma phospholipids by trichloro acetic acid precipitation. J. Lab. Clin. Med. 35 (1950) 155-160
30. Rao A.V., and Ramakrishnan S. Indirect assessment of hydroxymethylglutaryl-CoA reductase activity in liver tissue. Clin. Chem. 21 (1975) 1523-15228
31. Hitz J., Steinmetz J., and Siest G. Plasma lecithin cholesterol acyl transferase-reference values and effects of xenobiotics. Clin. Chim. Acta 133 (1983) 85-96
32. Dubois M., and Gilles K.A. Methods in Enzymology (1956), Academic Press, New York pp. 83-85
33. Wagner W.D. A more sensitive assay discriminating galactosamine and glucosamine in mixtures. Anal. Biochem. 94 (1979) 394-396
34. Dische Z., and Shettles L.B. Specific colour reactions of methylpentoses and spectrophotometric micromethod for their determination. J. Biol. Chem. 175 (1948) 595-603
35. Warren L. The thiobarbituric acid assay of sialic acids. J. Biol. Chem. 234 (1959) 1971-1975
36. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with folinphenol reagent. J. Biol. Chem. 193 (1951) 265-275
37. Mathew S., Menon P.V., and Kurup P.A. Effect of administration of vitamin A, ascorbic acid and nicotinamide adenine dinucleotide + flavin adenine dinucleotide on severity of myocardial infarction induced by isoproterenol in rats. Ind. J. Exp. Biol. 23 (1985) 500-504
38. Salter A.M., and White D.A. Effects of dietary fat on cholesterol metabolism; regulation of plasma LDL concentration. Nutr. Res. Rev. 9 (1996) 241-257
39. Gokkusu C., and Mostafazadeh T. Changes of oxidative stress in various tissues by long-term administration of vitamin E in hypercholesterolemic rats. Clin. Chim. Acta 328 (2003) 155-161
40. Anandan R., Mathew S., Sankar T.V., and Viswanathan Nair P.G. Protective effect of n-3 polyunsaturated fatty acids concentrate on isoproterenol-induced myocardial infarction in rats. Prostaglandins Leukot. Essent. Fatty Acids 76 (2007) 153-158
41. Jacksen G. Metabolic agents for stable angina. Heart Metabol. 1 (1998) 10-11
42. Crass M.F., Shipp J.C., and Pieper G.M. Effects of catacholamines on myocardial endogenous substrates and contractility. Am. J. Physiol. 228 (1975) 618-627
43. Vik-Mo H., and Mjos O.D. Influence of free fatty acids on myocardial oxygen consumption and ischemic injury. Am. J. Cardiol. 48 (1981) 361-365
44. Chien K.R., Sherman S.C., Mittnacht F, and Farber J.L. Microsomal membrane structure and function subsequent to calcium activation of an endogenous phospholipase. Arch. Biochem. Biophys. 205 (1980) 614-622
45. Franson R., Wiate M., and Weglicki W. Phospholipase A activity of lysosomes of rat myocardial tissue. J. Biochem. 11 (1972) 472-476
46. Esterbauer H., Gebicki J., Puhl H., and Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic. Biol. Med. 13 (1992) 341-390
47. Zachariah B., and Basu D. Surface carbohydrates in cell-biology. Ind. J. Biochem. Biophys. 30 (1993) 422-425
48. Judd J.T., and Wexler B.C. Myocardial connective tissue metabolism in response to injury. II. Investigation of the mucopolysaccharides involved in isoproterenol-induced necrosis and repair in rat hearts. Circ. Res. 26 (1970) 101-109
49. Mathew S., Menon P.V., and Kurup P.A. Changes in glycoproteins in isoproterenol-induced myocardial infarction in rats. Ind. J. Biochem. Biophys. 19 (1982) 41-43
50. Crook M.A., Earle K., Morocutti A., Yip J., Viberti G., and Pickup J.C. Serum sialic acid, a risk factor for cardiovascular disease, is increased in IDDM patients with microalbuminuria and clinical proteinuria. Diabetes Care 17 (1994) 305-310